Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 14 min ago
PreprintCC BY-NC-NDmedRxiv

Red blood cell distribution width is an indicator of physiological dysregulation and reveals the relationship between biomarkers and health status in hemodialysis patients

  1. 1Division of Nephrology, Yuai Clinic, Hakuyukai Medical Corporation

Abstract

IntroductionRed blood cell distribution width (RDW) and intra-individual variability (IIV) of biomarkers are different types of variation. Although their high levels are commonly associated with high mortality risks and poor clinical outcomes, the reason for this remains unclear.

MethodsWe explored the significance of this similarity using time-series data (from 143,475 samples) collected over a 9-year period from 1,216 patients on long-term hemodialysis. The IIV of each of the 22 blood-based biomarkers was assessed using the moving coefficient of variation (mCV). Non-linear longitudinal/temporal changes of the variables and their mutual relationships were analyzed using generalized additive (mixed) models.

ResultsRDW and all of the IIVs showed similar trends throughout the entire period of dialysis treatment: a rapid decrease after hemodialysis initiation followed by an increase that accelerated prior to death. The slopes of these downward and upward trends during each one-year period were statistically different from zero for RDW and the majority of the IIVs. Given the reported increase in the RDW and IIVs of several biomarkers in the pre-dialysis stages of chronic kidney disease, these shared changes might reflect alterations in homeostatic capacity. The RDW exhibited positive correlations with the mCVs of all 22 biomarkers (all p-values < 0.0009), suggesting that it represents dysregulation of the overall physiological system. Furthermore, the levels of the biomarkers showed a specific (nearly linear or U-shaped) relationship with the RDW, analogous to their reported relationship to all-cause mortality in the hemodialysis population.

ConclusionIncreased RDW could serve as a marker of physiological dysregulation, and measurement of the RDW can be an effective tool for assessing the overall health status and identifying optimal ranges for various health indicators.

Related

  1. Physiological discordance between clinical examination, bioimpedance spectroscopy, and lung ultrasound in maintenance hemodialysis patients without heart failure
    Irwing R. Benites-Flores, Javier Rodríguez Revilla, Alvaro Taype-Rondan +8
    Frontiers in nephrologyPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. The Relationship Between Symptom Experiences and Quality of Life in Patients on Hemodialysis: The Mediating Role of Positive Psychological Capital.
    Seung Won Ryu, Hye Young Kim, Won Hee Jun
    Healthcare (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Chronic Occupational Stress and Immune–Inflammatory Dysregulation: Mechanisms, Clinical Consequences, Biomarkers and Implications for Occupational Medicine
    Ancuța-Ramona Boicea Camen, Mihail Virgil Boldeanu, Daniel Cosmin Caragea +4
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. The study of Relationship between Dysregulation of RP11-446E9, HOTAIR, and P21 Long non-coding RNA and Acute Lymphocytic Leukemia Patients
    Nihayat Hussein Hamad, Zirak Faqe Ahmed Abdulrahman
    Tikrit Journal of Pure SciencePeer-reviewedCC BYFull textOncologyDOAJ
  5. MicroRNA cargo of extracellular vesicles as mediators of immune dysregulation in pediatric immune thrombocytopenia: from pathogenetic drivers to biomarkers.
    Lucia Argenziano, Maria Maddalena Marrapodi, Giuseppe Di Feo +3
    Frontiers in geneticsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@misc{nakazato2026blood,
  title = {{Red blood cell distribution width is an indicator of physiological dysregulation and reveals the relationship between biomarkers and health status in hemodialysis patients}},
  author = {Y. Nakazato and M. Shimoyama and H. Shimoyama and H. Kobayashi and H. Takao and H. Shimoyama},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.04.26362306},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.04.26362306v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Red blood cell distribution width is an indicator of physiological dysregulation and reveals the relationship between biomarkers and health status in hemodialysis patients
AU  - Y. Nakazato
AU  - M. Shimoyama
AU  - H. Shimoyama
AU  - H. Kobayashi
AU  - H. Takao
AU  - H. Shimoyama
PY  - 2026
DA  - 2026/09/04
PB  - medRxiv
DO  - 10.64898/2026.09.04.26362306
UR  - https://www.medrxiv.org/content/10.64898/2026.09.04.26362306v1
AB  - IntroductionRed blood cell distribution width (RDW) and intra-individual variability (IIV) of biomarkers are different types of variation. Although their high levels are commonly associated with high mortality risks and poor clinical outcomes, the reason for this remains unclear.  MethodsWe explored the significance of this similarity using time-series data (from 143,475 samples) collected over a 9-year period from 1,216 patients on long-term hemodialysis. The IIV of each of the 22 blood-based biomarkers was assessed using the moving coefficient of variation (mCV). Non-linear longitudinal/temporal changes of the variables and their mutual relationships were analyzed using generalized additive (mixed) models.  ResultsRDW and all of the IIVs showed similar trends throughout the entire period of dialysis treatment: a rapid decrease after hemodialysis initiation followed by an increase that accelerated prior to death. The slopes of these downward and upward trends during each one-year period were statistically different from zero for RDW and the majority of the IIVs. Given the reported increase in the RDW and IIVs of several biomarkers in the pre-dialysis stages of chronic kidney disease, these shared changes might reflect alterations in homeostatic capacity. The RDW exhibited positive correlations with the mCVs of all 22 biomarkers (all p-values < 0.0009), suggesting that it represents dysregulation of the overall physiological system. Furthermore, the levels of the biomarkers showed a specific (nearly linear or U-shaped) relationship with the RDW, analogous to their reported relationship to all-cause mortality in the hemodialysis population.  ConclusionIncreased RDW could serve as a marker of physiological dysregulation, and measurement of the RDW can be an effective tool for assessing the overall health status and identifying optimal ranges for various health indicators.
ER  -